Literature DB >> 17268581

Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis.

Markus J Seibel1.   

Abstract

With the ageing population in most countries, disorders of bone and mineral metabolism are becoming increasingly relevant to every day clinical practice. Consequently, the interest in, and the need for effective measures to be used in the screening, diagnosis and follow-up of such pathologies have markedly grown. Together with clinical and imaging techniques, biochemical tests play an important role in the assessment and differential diagnosis of metabolic bone disease. These biochemical indices are non-invasive, comparatively inexpensive and, when applied and interpreted correctly, helpful tools in the diagnostic and therapeutic assessment of metabolic bone disease. This second part of the two part series reviews the current evidence regarding the clinical use of biochemical markers of bone remodelling in the management of osteoporosis.

Entities:  

Year:  2006        PMID: 17268581      PMCID: PMC1579289     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  146 in total

1.  Hormone combination treats women's bone loss.

Authors:  C Marwick
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

2.  Markers of bone resorption in patients treated with pamidronate.

Authors:  A Lipton; L Demers; E Curley; V Chinchilli; L Gaydos; G Hortobagyi; R Theriault; D Clemens; L Costa; J Seaman; R Knight
Journal:  Eur J Cancer       Date:  1998-12       Impact factor: 9.162

Review 3.  Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis.

Authors:  Julie M Blair; Hong Zhou; Markus J Seibel; Colin R Dunstan
Journal:  Nat Clin Pract Oncol       Date:  2006-01

4.  Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.

Authors:  S T Harris; E F Eriksen; M Davidson; M P Ettinger; A H Moffett; D J Baylink; C E Crusan; A A Chines
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

5.  Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.

Authors:  F H Anderson; R M Francis; R T Peaston; H J Wastell
Journal:  J Bone Miner Res       Date:  1997-03       Impact factor: 6.741

6.  Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Authors:  P Garnero; E Sornay-Rendu; M C Chapuy; P D Delmas
Journal:  J Bone Miner Res       Date:  1996-03       Impact factor: 6.741

7.  Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.

Authors:  K Akesson; S Ljunghall; B Jonsson; I Sernbo; O Johnell; P Gärdsell; K J Obrant
Journal:  J Bone Miner Res       Date:  1995-11       Impact factor: 6.741

8.  Serum osteocalcin increases during fracture healing in elderly women with hip fracture.

Authors:  K Akesson; P Vergnaud; P D Delmas; K J Obrant
Journal:  Bone       Date:  1995-04       Impact factor: 4.398

9.  Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.

Authors:  Lars Rejnmark; Niels Henrik Buus; Peter Vestergaard; Lene Heickendorff; Frederik Andreasen; Mogens Lytken Larsen; Leif Mosekilde
Journal:  J Bone Miner Res       Date:  2004-02-16       Impact factor: 6.741

10.  Exploring the relationship between surrogates and clinical outcomes: analysis of individual patient data vs. meta-regression on group-level summary statistics.

Authors:  Zhengqing Li; Michael P Meredith
Journal:  J Biopharm Stat       Date:  2003-11       Impact factor: 1.051

View more
  34 in total

Review 1.  Oral contraceptive use and bone.

Authors:  Shuying Wei; Tania Winzenberg; Laura L Laslett; Alison Venn; Graeme Jones
Journal:  Curr Osteoporos Rep       Date:  2011-03       Impact factor: 5.096

2.  Soluble Tumor Necrosis Factor Alpha Receptor 1, Bone Resorption, and Bone Mineral Density in the Year Following Hip Fractures: The Baltimore Hip Studies.

Authors:  Shabnam Salimi; Michelle Shardell; Ram Miller; Ann L Gruber-Baldini; Denise Orwig; Neal Fedarko; Marc C Hochberg; Jack M Guralnik; Jay Magaziner
Journal:  J Bone Miner Res       Date:  2018-06-15       Impact factor: 6.741

3.  The role of biochemical markers of bone turnover in osteoporosis management in clinical practice.

Authors:  Samuel D Vasikaran; Paul Glendenning; Howard A Morris
Journal:  Clin Biochem Rev       Date:  2006-08

4.  Heterogeneity of biological bone markers in idiopathic male osteoporosis.

Authors:  Michel Laroche
Journal:  Rheumatol Int       Date:  2011-04-17       Impact factor: 2.631

5.  Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.

Authors:  Maria Swanberg; Fiona McGuigan; Kaisa K Ivaska; Paul Gerdhem; Ulf H Lerner; Richard Bucala; George Kuchel; Anne Kenny; Kristina Akesson
Journal:  Bone       Date:  2010-05-12       Impact factor: 4.398

6.  Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice.

Authors:  I Baxter; A Rogers; R Eastell; N Peel
Journal:  Osteoporos Int       Date:  2012-08-08       Impact factor: 4.507

7.  A biochemical approach for assessing cutoffs at the age thresholds of 14 and 18 years: a pilot study on the applicability of bone specific alkaline phosphatase on an Italian sample.

Authors:  Marco Tisè; Luigi Ferrante; Stefano Mora; Adriano Tagliabracci
Journal:  Int J Legal Med       Date:  2016-05-12       Impact factor: 2.686

8.  Nanoparticles of cobalt-substituted hydroxyapatite in regeneration of mandibular osteoporotic bones.

Authors:  Nenad Ignjatović; Zorica Ajduković; Vojin Savić; Stevo Najman; Dragan Mihailović; Perica Vasiljević; Zoran Stojanović; Vuk Uskoković; Dragan Uskoković
Journal:  J Mater Sci Mater Med       Date:  2012-10-23       Impact factor: 3.896

Review 9.  Bone turnover in nutrition-related disorders.

Authors:  Markus J Seibel
Journal:  Wien Med Wochenschr       Date:  2007

Review 10.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.